China's space station to welcome first foreign astronaut in next few years, Xinhua says
BEIJING, Feb 28 (Reuters) - China and Pakistan signed a cooperation agreement on the selection and training of astronauts on Friday, Xinhua reported.
The agreement marks the first time China will be training astronauts for another country, the report said, adding that China's space station will welcome its first foreign astronaut in the next few years.
The Technology Roundup newsletter brings the latest news and trends straight to your inbox. Sign up here.
Reporting by Xiuhao Chen and Ryan Woo; Editing by Kevin Liffey
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
5 minutes ago
- Reuters
Russia fines Apple for violating 'LGBT propaganda' law, TASS reports
MOSCOW, June 10 (Reuters) - A Russian court on Tuesday fined U.S. tech giant Apple (AAPL.O), opens new tab six million roubles ($76,510) for violating Russian rules on what Moscow calls "LGBT propaganda," the state TASS news agency reported. Russia in 2023 widened existing restrictions on the promotion of "non-traditional sexual relations" amid a broader crackdown on LGBT rights, part of President Vladimir Putin's push to uphold what he calls traditional values. Apple was fined three million roubles in two civil cases on Tuesday, TASS reported. Apple was last month fined a total of 7.5 million roubles for the same offence. Apple (AAPL.O), opens new tab did not immediately respond to an emailed request for comment. ($1 = 78.4205 roubles)
Reuters
9 minutes ago
- Reuters
AI company Glean hits $7.2 billion in valuation in latest funding round
June 10 (Reuters) - U.S. enterprise AI search startup Glean said on Tuesday it had notched a $7.2 billion valuation in its latest funding round, led by asset manager Wellington Management. The company raised $150 million in a Series F funding round, which also included participation from new investors including Khosla Ventures. The latest investment will help Glean to enhance its product offerings and bolster international presence, the company said.
Reuters
10 minutes ago
- Reuters
Novo Nordisk starts new CagriSema weightloss drug trial
COPENHAGEN, June 10 (Reuters) - Novo Nordisk ( opens new tab has launched a new late-stage trial for its experimental next-generation obesity drug candidate, CagriSema, as it tries to reassure the market of its potential after disappointing data from two previous studies. The Danish company made the announcement in an entry published on opens new tab "This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term," Novo Nordisk said in the entry.
